Boehringer Ingelheim ( Boehringer-Ingelheim )


Boehringer-Ingelheim's picture

About Boehringer Ingelheim

Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies. Learn more about the financial highlights, the corporate vision, the organisation, the Board of Managing Directors and the company's history as well as our engagement for scientific, cultural and environmental purposes.

Boehringer-Ingelheim press release, blog etc

11/06/2018 - 23:07 Boehringer Ingelheim becomes an official partner to CatCare for Life
10/31/2018 - 11:28 Boehringer Ingelheim achieves next expansion milestone in biologics production in the US
10/25/2018 - 11:26 Boehringer Ingelheim inaugurates new centre for agile working methods: more and better health solutions for humans and animals
10/23/2018 - 11:53 Boehringer Ingelheim announces the winners of 2018 BVDzero Case Awards
10/19/2018 - 10:02 Real-world study shows using Giotrif
10/11/2018 - 23:16 Boehringer Ingelheim increases awareness of health with the micro enterprise project Elephants in South India
10/11/2018 - 22:49 Boehringer Ingelheim inaugurates its new global centre for veterinary vaccine R&D in Lyon, France
09/30/2018 - 22:13 2018 Animal Welfare Medals: Boehringer Ingelheim recognizes outstanding research in animal health
09/27/2018 - 22:18 Boehringer Ingelheim is committed to joining forces in the global fight against rabies
09/27/2018 - 01:09 New vaccine against Bovine Respiratory Disease: Boehringer Ingelheim reaffirms its focus on prevention
09/26/2018 - 00:47 Global survey reveals that physicians need more information to assess the impact of treatment sequencing on patient survival in EGFR mutation-positive NSCLC
09/24/2018 - 22:59 Results of LUME-Meso trial in malignant pleural mesothelioma presented at the 19 th World Conference on Lung Cancer (WCLC 2018)
09/13/2018 - 13:58 Boehringer Ingelheim Acquires All ViraTherapeutics Shares to Develop Next Generation Viral-Based Immuno-Oncology Therapies
09/10/2018 - 09:19 Changes to the Leadership of Boehringer Ingelheims Corporate Department Medicine
09/04/2018 - 22:21 Boehringer Ingelheim launches the first liquid solution for hypertension in cats
09/03/2018 - 22:17 Boehringer Ingelheim and Tsinghua University Team up to Develop Novel Treatment Approaches that Rally the Immune System Against Infectious Diseases
09/03/2018 - 14:37 Boehringer Ingelheim Biopharmaceuticals China supports BeiGene in its China NDA submission of anti-PD-1 antibody, tislelizumab
08/21/2018 - 15:55 New tablet production facility in Ingelheim: Centerpiece for global launches